4 Marijuana Stocks That Look Profitable in 2019

Marijuana stocks may not have had a stellar year in 2018.  But, this year could easily bring better news as such markets continue to expand and more new marijuana markets open up.

Canada has become the first country to legalize recreational weed last October. This development has, undoubtedly, cemented the way for billions of dollars in legitimate annual sales and has helped the pot market to come out from the shadows and into the limelight as a reliable business model.

A number of developments happened in the United States as well. President Trump signed the Farm bill into law last November, legalized hemp and cannabis-based products throughout the country.

To top it, the U.S. Food and Drug Administration approved the first cannabis-derived drug, with quite a number of U.S. states giving green signal to cannabis in some capacity last year. Nearly two-thirds of all the states in the United States have legalized medical marijuana and 10 of them, in fact, allowed adult consumption.

Companies in this up-and-coming industry, thus, have taken aggressive steps to raise cash, go public and list their shares on the U.S. bourses to access capital. Hence, looking at some of the stocks from this fast-growing industry doesn’t seem like a bad proposition.

Marijuana Sales to Skyrocket

According to Arcview Market Research and BDS Analytics, global consumer marijuana outlays are estimated to climb 38% to $16.9 billion this year, up from a projected $12.2 billion last year, $9.5 billion in 2017, and $6.9 billion in 2016. Additionally, compounded global annual sales growth of cannabis from 2017 to 2022 is expected at $31.3 billion.

While legalization of marijuana in several U.S. states and in Canada will surely help cannabis growth to hit such a promising number by 2022, a number of dispensaries have been given the permit to sell legalized cannabis. At the same time, mergers and acquisitions between large beverage, tobacco, pharma and cannabis companies should certainly help the weed market grow. After all, deal making will diversify their product portfolio and propel growth.

Investment bank Cowen & Co said that the legal weed market is expected to reach a worth of as much as $75 billion by 2030. This indicates that there are plenty of opportunities for investors to make money from both direct and subsidiary players.

Fast-Growing Marijuana Stocks to Consider in 2019

As excellent prospects are expected to make marijuana stocks winners this year, take a look at these selected few poised to move north this year. All these stocks possess a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

GW Pharmaceuticals plc GWPH focuses on discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. The cannabinoid drug maker is expected to see an uptick in sales this year, especially, after its lead drug; Epidiolex became the first cannabis-derived drug to gain approval from the Food and Drug Administration.

GW Pharmaceuticals is projected to gain 4.2% in the next quarter. The company has outperformed the Medical - Products industry so far this year (+40.9% vs +2.9%).

Innovative Industrial Properties, Inc. IIPR focuses on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities.